Crossmark

Evidenz stützt Potenzial von SGLT-2-Inhibitioren

Crossref DOI link: https://doi.org/10.1007/s11298-022-2432-9

Published Online: 2022-06-17

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Willen, Christine
License Information

Text and Data Mining valid from 2022-06-01

Version of Record valid from 2022-06-01
More Information

Article History

First Online: 17 June 2022

Free to read: This content has been made available to all.